Clinical Trials on Healthy Adult Volunteers in United States

Total 10938 results

Pfizer

Completed

Study To Determine The Effect Of Food And Strong CYP3A4 Enzyme Inhibitor On PF-04449913 Drug Levels

Healthy Volunteers

United States
AstraZeneca

Completed

A Study to Assess the Bioequivalence of R406 in Healthy Volunteers When Given 100mg and 150 mg of Fostamatinib (Fosta BE)

Healthy Volunteers

United States
AstraZeneca

Completed

A Randomized, Open Label Study to Compare the Current Phase II and Planned Phase III Capsule Formulation of AZD6244 (AZD6244Formula)

Healthy Volunteers

United States
Pfizer

Completed

Study To Investigate The Potential Drug Drug Interaction (DDI) Between PF-00299804 And Paroxetine In Healthy Subjects

Healthy Volunteers

United States
University of California, San Francisco

Completed

Analgesic Tolerance to Repeated Doses of Subcutaneous Morphine

Healthy Volunteers

United States
Pfizer

Terminated

Muscle Malonyl Coa Biomarker Assay Development

Healthy Volunteers

United States
Pfizer

Completed

Drug Interaction Study Between Raltegravir And UK-453,061

Healthy Volunteers

United States
Medical University of South Carolina
GE Healthcare

Completed

The Effect of Contrast Media on Erythrocytes in Healthy Volunteers

Healthy Volunteers

United States
Bristol-Myers Squibb

Recruiting

A Study to Assess the Relative Bioavailability of 5 mg Mavacamten Opened Capsule Administered Via Nasogastric Tube Compared to Intact Oral 5 mg Mavacamten in Healthy Participants

Healthy Volunteers

United States
Eisai Inc.

Completed

A Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2086 in Healthy Adult and Elderly Participants

Healthy Volunteers

United States
Cerevel Therapeutics, LLC

Completed

A Trial to Evaluate the Effects of Itraconazole and Carbamazepine on the Pharmacokinetics of Emraclidine and of Emraclidine on the Pharmacokinetics of Metformin in Healthy Adult Participants

Healthy Volunteers

United States
Eisai Inc.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of E2025 in Healthy Participants

Healthy Volunteers

United States
University of Michigan
Archimedes Innovations, Pbc

Active, not recruiting

The Effect of Violet Device Dosed Ultra Violet-C Light (UV-C) Exposure on Healthy Hand Skin

Healthy Volunteers

United States
Reata, a wholly owned subsidiary of Biogen

Completed

An Open-Label Study of the Effect of Bardoxolone Methyl on the Single Dose Pharmacokinetics of Digoxin and Rosuvastatin in Healthy Volunteers

Healthy Volunteers

United States
Shionogi

Completed

A Study to Assess the Effect of Cefiderocol on the Pharmacokinetics (PK) of Midazolam in Healthy Participants

Healthy Volunteers

United States
Duke University

Suspended

Modeling Organ Motion During Abdominal Imaging in Healthy Volunteers

Healthy Volunteers

United States
Medical University of South Carolina

Completed

Reshaping the Motor Engram - An Online Crowdsourcing Study. (FORGET)

Healthy Volunteers

United States
Takeda

Completed

A Study of Soticlestat in Healthy Adult Nondependent Recreational Drug Users With Central Nervous System (CNS) Depressant Experience

Healthy Volunteers

United States
Cornell University

Completed

The Role of Dietary Intake and Host Genetics in Gut Microbiome Response to Resistant Starch Consumption

Healthy Volunteers

United States
Intra-Cellular Therapies, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITI 333 in Healthy Volunteers

Healthy Volunteers

United States
Celgene

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-99677 in Healthy Adult Japanese Participants.

Healthy Volunteers

United States
University of Michigan

Completed

Exercise Induced Changes in Fat Metabolism (BC)

Healthy Volunteers

United States
Takeda

Terminated

A Study With [18F]MNI-1054 to Determine Lysine -Specific Demethylase 1A (LSD1) Brain Enzyme Occupancy of TAK-418 After Single-Dose Oral Administration in Healthy Participants

Healthy Volunteers

United States
Biogen

Completed

Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB104 in Healthy Japanese and Non-Japanese Participants

Healthy Volunteers

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Bioavailability of 3 Sildenafil Oral Disintegrating Tablet Formulations Compared to the Standard Oral Tablet

Healthy Volunteers

United States
Hanmi Pharmaceutical Company Limited

Completed

Molar Potency Study of HM12460A in Healthy Subjects

Healthy Volunteers

United States
MediciNova

Completed

Relative Bioavailability of MN-166 (Ibudilast) in Extended Release Tablet vs. Intermediate-release Capsule in Healthy Volunteers

Healthy Volunteers

United States
Daiichi Sankyo, Inc.

Completed

Effect of Low-Fat Food on Pexidartinib Pharmacokinetics in Healthy Volunteers

Healthy Volunteers

United States
BeiGene

Completed

A Two-Part Phase 1 Study to Investigate the Safety and Tolerability of Supratherapeutic Dose of Zanubrutinib and Effect of Zanubrutinib on Cardiac Repolarization in Healthy Subjects

Healthy Volunteers

United States
Sucampo Pharma Americas, LLC
Takeda

Completed

Comparative Pharmacokinetics and Food-Effect Bioavailability of Lubiprostone Sprinkle in Healthy Volunteers

Healthy Volunteers

United States
Bausch Health Americas, Inc.

Completed

Safety and Gastrointestinal Effects of Intravenous Methylnaltrexone

Healthy Volunteers

United States
Pfizer

Completed

Evaluate Taste and Relative Bioavailability of Two Microsphere Formulations of Crizotinib in Healthy Participants

Healthy Volunteers

United States
Spire, Inc.

Completed

Spire Medical Health Tag Actigraphy and Sleep Validation in Adults

Healthy Volunteers

United States
Celgene

Completed

Drug-drug Interaction Study of Ozanimod With Pseudoephedrine to Evaluate the Effect on Blood Pressure and Heart Rate

Healthy Volunteers

United States
Invicro

Completed

Assessment of the Biodistribution and Safety of [18F]MNI-958 in Healthy Subjects

Healthy Volunteers

United States
Hoffmann-La Roche

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Risdiplam (RO7034067) in Healthy Japanese Participants

Healthy Volunteers

United States
Eli Lilly and Company

Completed

A Study of Evacetrapib in Healthy Participants

Healthy Volunteers

United States
Aelis Farma
National Institute on Drug Abuse (NIDA)

Completed

Single Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117

Healthy Volunteers

United States
Molecular NeuroImaging

Completed

Phase 0 Study of [18F]MNI-968 as a Marker for D1 Receptor in Healthy Subjects

Healthy Volunteers

United States
Molecular NeuroImaging

Completed

Assessment of the Biodistribution and Safety of [18F]MNI-968 in Healthy Subjects

Healthy Volunteers

United States
GlycoMimetics Incorporated
University of Michigan

Completed

Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects

Healthy Volunteers

United States
UCB Pharma
Yale University; PRA Health Sciences

Completed

A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy Volunteers

Healthy Volunteers

United States
Pfizer

Completed

A Study Of Glasdegib In Healthy Volunteers To Establish The Bioequivalence Of The Phase 2 Formulation To The ICH Formulation (B1371026)

Healthy Volunteers

United States
Celgene

Completed

A Study to Assess the Relative Bioavailability of a New CC-220 Capsule Formulation, Compared to a Reference CC-220 Capsule Formulation, in Healthy Adult Subjects

Healthy Volunteers

United States
Calithera Biosciences, Inc

Completed

A Comparative, Pharmacokinetic Study of CB-839 Capsule and Tablet Formulations in Healthy Adults

Healthy Volunteers

United States
Takeda

Terminated

MLN3126 Single Rising Dose Study

Healthy Volunteers

United States
Olatec Therapeutics LLC

Completed

Phase 1 Safety and PK Study of OLT1177 Capsules

Healthy Volunteers

United States
GliaCure, Inc.

Completed

Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Doses of GC021109 in Healthy Subjects

Healthy Volunteers

United States
Eli Lilly and Company

Completed

A Study of Axiron® in Healthy Participants

Healthy Volunteers

United States
Janssen Research & Development, LLC
Pharmacyclics LLC.

Completed

A Study to Determine the Effect of Food on the Pharmacokinetics of PCI-32765

Healthy Volunteers

United States

3

Subscribe